Birkmeyer J D, Quinton H B, O'Connor N J, McDaniel M D, Leavitt B J, Charlesworth D C, Hernandez F, Ricci M A, O'Connor G T
Department of Surgery, Dartmouth Medical School, Hanover, New Hampshire, USA.
Arch Surg. 1996 Mar;131(3):316-21. doi: 10.1001/archsurg.1996.01430150094018.
To examine the effect of peripheral vascular disease (PVD) on long-term mortality after successful myocardial revascularization.
We performed a regional cohort study of 2871 consecutive patients discharged alive after coronary artery bypass graft surgery at five tertiary care centers in Maine, New Hampshire, and Vermont between 1987 and 1989. Data reflecting patient characteristics, heart disease severity, and comorbidity were collected prospectively; the presence of clinical and subclinical indicators of PVD was determined by medical record review; and vital status was determined using the National Death Index (mean follow-up, 4.4 years).
Five-year mortality following coronary artery bypass graft surgery was substantially higher in the 755 patients with indicators of PVD (20%; 95% confidence interval [CI], 17% to 23%) than in the 2116 patients without PVD (8%, 95% CI, 7 to 9; P<.001). The crude hazard ratio of long-term mortality associated with PVD was 2.77 (95% CI, 2.19 to 3.50; P<.001). After adjusting for their higher comorbidity scores, more advanced cardiac disease, and age, mortality rates in patients with PVD remained twice as high as those in patients without PVD (adjusted hazard ratio, 2.01; 95% CI, 1.57 to 2.58; P<.001). Long-term mortality was increased in patients with any of the indicators of PVD. Patients with multilevel PVD had especially high late mortality rates (adjusted hazard ratio, 2.46; 95% CI, 1.64 to 3.68; P<.001).
Even after successful myocardial revascularization, patients with PVD remain at substantially increased risk for long-term mortality. The presence of clinical or subclinical PVD is important when predicting both short- and long-term outcomes in patients considering coronary artery bypass graft surgery.
探讨外周血管疾病(PVD)对心肌血运重建成功后长期死亡率的影响。
我们对1987年至1989年间在缅因州、新罕布什尔州和佛蒙特州的五个三级医疗中心接受冠状动脉旁路移植手术后存活出院的2871例连续患者进行了一项区域性队列研究。前瞻性收集反映患者特征、心脏病严重程度和合并症的数据;通过病历审查确定PVD的临床和亚临床指标的存在情况;使用国家死亡指数确定生命状态(平均随访4.4年)。
755例有PVD指标的患者冠状动脉旁路移植手术后的五年死亡率(20%;95%置信区间[CI],17%至23%)显著高于2116例无PVD的患者(8%,95%CI,7%至9%;P<0.001)。与PVD相关的长期死亡率的粗风险比为2.77(95%CI,2.19至3.50;P<0.001)。在调整了较高的合并症评分、更晚期的心脏病和年龄后,PVD患者的死亡率仍然是无PVD患者的两倍(调整后的风险比,2.01;95%CI,1.57至2.58;P<0.001)。任何PVD指标的患者长期死亡率均升高。多节段PVD患者的晚期死亡率尤其高(调整后的风险比,2.46;95%CI,1.64至3.68;P<0.001)。
即使心肌血运重建成功,PVD患者的长期死亡风险仍显著增加。在预测考虑冠状动脉旁路移植手术患者的短期和长期结局时,临床或亚临床PVD的存在很重要。